5.19
+0.02
+(0.39%)
At close: January 10 at 4:00:02 PM EST
5.29
+0.10
+(1.93%)
After hours: January 10 at 4:43:37 PM EST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -0.11 | -0.14 | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
Currency in USD | 3/31/2020 | 6/30/2020 | 9/30/2020 | 12/31/2020 |
---|---|---|---|---|
EPS Est. | -- | -0.1 | -0.08 | -0.04 |
EPS Actual | -0.02 | -0.11 | -0.04 | 0.03 |
Difference | -- | -0.01 | 0.04 | 0.07 |
Surprise % | -- | -10.00% | 50.00% | 175.00% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2021) | Next Year (2022) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 1 | -- |
Up Last 30 Days | -- | -- | 1 | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ICCC | -- | -- | -- | -- |
S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
Initiated | Aegis Capital: Buy | 7/13/2020 |
Related Tickers
SPHDF Santhera Pharmaceuticals Holding AG
9.42
0.00%
145020.KQ Hugel, Inc.
260,000.00
-1.52%
DOSE.CN Rapid Dose Therapeutics Corp.
0.2250
-6.25%
HMTXF Hemostemix Inc.
0.1670
+108.49%
CLDWW Calidi Biotherapeutics, Inc.
0.0091
+506.67%
CSBR Champions Oncology, Inc.
9.47
-1.97%
BVAXF BioVaxys Technology Corp.
0.0460
+9.00%
ACHL Achilles Therapeutics plc
1.1850
-0.42%
ANEB Anebulo Pharmaceuticals, Inc.
1.4600
-10.43%
WXXWY WuXi Biologics (Cayman) Inc.
4.2900
+2.39%